Rosenau Family Research Foundation
https://www.rosenaufoundation.org
$38.1M
Total Assets (2024)
$3.2M
Total Giving (2024)
44
Grants on File (2023–2024)
$134K
Avg Grant Size
Focus Areas
Application Information
Accepts Unsolicited Proposals
Unknown
Contact Person
Paul Rosenau
Phone
5078338144
Deadlines
None
How to Apply
Letter Outlining Project - Including Financial Data
Restrictions
Childhood Diseases and Newborn Screening for Disease - Particularly Krabbe's and Cystic Fibrosis
Financial Trends
Giving Over Time
Total Assets Over Time
View financial data as table
| Year | Total Giving | Total Assets | Revenue | Grants |
|---|---|---|---|---|
| 2023 | $2.6M | $32.1M | $2.3M | 20 |
| 2024 | $3.2M | $38.1M | $8.2M | 24 |
Grant Size Distribution
Min: $18K
Median: $125K
Avg: $132K
Max: $400K
Geographic Distribution
Key Personnel
| Name | Title | Compensation |
|---|---|---|
| Heather Techmeier | Director | $188K |
| Dr Gabriel Cohn | Director | $175K |
| Karlita Blackwell | Director | — |
| Paul Rosenau | President | — |
| Gillian Hauboldt | Treasurer | — |
| Mary Kay Delvo Amanda Post | Secretary | — |
| Julie McCarrier | Director | — |
| Li Ou | Director | — |
| Phil Christianson | Director | — |
| Marci Sontag | Director | — |
| Mariah Stone Mary Kay Delvo | Secretary | — |
Grants Awarded (44 total)
| Recipient | Location | Amount | Purpose | Year |
|---|---|---|---|---|
| Children's Hospital of Chicago | Chicago, IL | $400,000 | Caregiver and Clinician Awareness for Early CF | 2023 |
| Duke University | Durham, NC | $375,000 | Improving KD Family Experience Through Communication and Promoting | 2023 |
| UW Department of Pediatrics | Madison, WI | $250,000 | Enriching CF Newborn Screening Outcomes Through a Precision Personalized Medicine Strategy | 2024 |
| Duke University | Durham, NC | $250,000 | Immune Responses in Peripheral Nerves after Hematopoietic Stem Cell Transplants for KD | 2024 |
| Nationwide Children's Hospital | Columbus, OH | $250,000 | Evaluation of In Utero Gene Therapy in Canine KD | 2024 |
| University of Illinois | Chicago, IL | $250,000 | Immune Responses in Peripheral Nerves after Hematopoietic Stem Cell Transplants for KD | 2023 |
| University of Pittsburgh | Pittsburgh, PA | $250,000 | Disclosure of Newborn Screening Results for KD in Pennsylvania | 2024 |
| University of Minnesota | Minneapolis, MN | $235,000 | GenoKrabbe: A Comprehensive Genotype-Phenotype Database for KD | 2024 |
| University of Buffalo | Amherst, NY | $205,983 | Innovative Model Systems to Study & Boost Innate Immunity in KD | 2023 |
| University of Connecticut Health Ce | Farmington, CT | $175,049 | Evaluation of Immunomodulatory Therapy for the Treatment of KD | 2024 |
| University of Illinois | Chicago, IL | $170,000 | Challenging the Capacity of AAV-GALC Gene Therapy to Cope with Modifiers of Adult Brain Function | 2023 |
| Biomedical Research Institute of NJ | Cedar Knools, NJ | $149,154 | Psychosine Profiling and Evaluation as a Therapeutic for KD | 2023 |
| Biomedical Research Institute of NJ | Cedar Knools, NJ | $149,154 | Psychosine Profiling and Evaluation as a Therapeutic for KD | 2024 |
| Biomedical Research Institute of NJ | Cedar Knools, NJ | $129,834 | Psychosine Profiling and Evaluation as a Therapeutic for KD | 2023 |
| University of Illinois | Chicago, IL | $125,000 | A Maladaptive Pathway Involved In Early Pathogenesis of KD | 2024 |
| University of Illinois | Chicago, IL | $125,000 | Immune Responses in Peripheral Nerves after Hematopoietic Stem Cell Transplants for KD | 2023 |
| University of Buffalo | Amherst, NY | $125,000 | Modulating Oligodendroglial NFkB as a Therapeutic Strategy for KD | 2024 |
| Duke University | Durham, NC | $125,000 | Immune Responses in Peripheral Nerves after Hematopoietic Stem Cell Transplants for KD | 2024 |
| University of Minnesota | Minneapolis, MN | $125,000 | GenoKrabbe: A Comprehensive Genotype-Phenotype Database for KD | 2024 |
| University of Pittsburgh | Pittsburgh, PA | $125,000 | Disclosure of Newborn Screening Results for KD in Pennsylvania | 2024 |
| Nationwide Children's Hospital | Columbus, OH | $125,000 | Evaluation of In Utero Gene Therapy in Canine KD | 2024 |
| University of Illinois | Chicago, IL | $125,000 | A Maladaptive Pathway Involved In Early Pathogenesis of KD | 2024 |
| University of Buffalo | Amherst, NY | $125,000 | Modulating Oligodendroglial NFkB as a Therapeutic Strategy for KD | 2024 |
| KrabbeConnect | Rosemount, MN | $123,982 | Parent-Reported Disease Burden in Infantile & Late Infantile KD | 2024 |
| KrabbeConnect | Rosemount, MN | $123,982 | Parent-Reported Disease Burden in Infantile & Late Infantile KD | 2023 |